Regenerative approaches aimed at modulating mTOR network activation patterns hold promise for delaying age-related vascular diseases and treatment of accelerated arteriosclerosis in chronic metabolic conditions. The gene discussed is MTOR; the disease is arteriosclerosis disorder.